Arrivent BiopharmaAVBP 13F holders, Q1 2024 (March 31) 53 holders
3 famous investors
$17.80 avg. 13F price*
At the end of Q1 2024 , 53 institutions reported holding Arrivent Biopharma Inc. (AVBP) in their 13F filings. The largest holders were HHLR Advisors, LTD. ($70.2M), Orbimed Advisors LLC ($54.1M) and FMR LLC ($34.8M). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Steve Cohen (0.0% of Point72 Asset Management's portfolio).
Company Arrivent Biopharma Inc.
CUSIP 04272N102
Latest filing quarter Q2 2026 History Number of 13F holders
Total Exit/New Position Q1 2024 Institutions Total Value New Positions 53 $388.5M Exits 0 $0
Ownership 53 holders Portfolio Manager % of Holder's Portfolio Change Shares Value ▼ HHLR Advisors, LTD. 1.52% New 3,929,117 $70.2M Orbimed Advisors LLC 0.99% New 3,027,328 $54.1M FMR LLC 0.00% New 1,950,034 $34.8M Octagon Capital Advisors LP 4.22% New 1,943,836 $34.7M Sofinnova Investments, Inc. 1.79% New 1,696,752 $30.3M Montanova Capital, LLC 1.18% New 1,563,709 $27.9M General Catalyst Group Management, LLC 2.05% New 1,494,786 $26.7M Novo Holdings A/S 1.33% New 1,077,140 $19.2M BlackRock Inc. 0.00% New 654,804 $11.7M Vanguard Group Inc. 0.00% New 648,735 $11.6M HSG Holding Ltd 0.97% New 663,308 $10.5M Altitude Crest Partners Inc. 4.25% New 555,555 $9.9M Cormorant Asset Management, LP 0.41% New 515,000 $9.2M Perceptive Advisors LLC 0.13% New 415,000 $7.4M Citadel Advisors 0.01% New 286,512 $5.1M Geode Capital Management, LLC 0.00% New 225,049 $4.0M Millennium Management 0.00% New 211,689 $3.8M Farallon Capital Management, L.L.C. 0.02% New 151,768 $2.7M State Street Corp. 0.00% New 122,264 $2.2M Woodline Partners LP 0.02% New 100,000 $1.8M AlphaCentric Advisors LLC 0.89% New 83,000 $1.5M Northern Trust Corp. 0.00% New 78,409 $1.4M Charles Schwab Investment Management Inc. 0.00% New 77,760 $1.4M Ghisallo Capital Management LLC 0.11% New 50,000 $893K Jane Street Group, LLC 0.00% New 36,959 $660K MYDA Advisors LLC 0.19% New 30,000 $536K Point72 Asset Management 0.00% New 28,900 $516K OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 0.01% New 26,181 $468K Walleye Capital LLC 0.01% New 25,000 $447K Blackstone Inc. 0.00% New 25,000 $447K Bank of New York Mellon Corp 0.00% New 22,707 $406K Point72 (DIFC) Ltd 0.03% — 21,890 $391K Morgan Stanley 0.00% New 21,141 $378K Barclays PLC 0.00% New 14,208 $254K Nuveen Asset Management, LLC 0.00% New 12,932 $231K JPMorgan Chase & Co. 0.00% New 12,556 $224K UBS Group AG 0.00% New 9,895 $177K Rhumbline Advisers 0.00% New 9,765 $174K MetLife Investment Management, LLC 0.00% New 5,514 $98K American International Group, Inc. 0.00% New 4,845 $87K BNP Paribas Financial Markets 0.00% New 4,659 $83K Cubist Systematic Strategies, LLC 0.00% New 4,360 $78K Wells Fargo & Company 0.00% New 3,231 $58K Bank of America Corp. 0.00% New 2,259 $40K Citigroup Inc. 0.00% New 1,741 $31K STRS Ohio 0.00% New 1,700 $30K California State Teachers Retirement System 0.00% New 989 $18K Ameritas Investment Partners, Inc. 0.00% New 981 $18K Legal & General Group Plc 0.00% New 896 $16K Tower Research Capital LLC (TRC) 0.00% New 604 $11K Metropolitan Life Insurance Co 0.00% New 567 $10K Amalgamated Bank 0.00% New 540 $10K Royal Bank of Canada 0.00% New 369 $7K
"% of holder's portfolio" is AVBP's weight in each manager's 13F, not the share of Arrivent Biopharma Inc. the manager owns.